CoChat

Sustained plasma hepcidin suppression and iron elevation by Anticalin‐derived hepcidin antagonist in cynomolgus monkey

Open access
Hohlbaum, Andreas M, Gille, Hendrik, Trentmann, Stefan, Kolodziejczyk, Maria, Rattenstetter, Barbara, Laarakkers, Coby M, Katzmann, Galina, Christian, Hans Jürgen, Andersen, Nicole, Allersdorfer, Andrea, Olwill, Shane A, Meibohm, Bernd, Audoly, Laurent P, Swinkels, Dorine W, van Swelm, Rachel P L · 2018 · British Journal of Pharmacology
Cited by 42

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Background and Purpose: Anaemia of chronic disease (ACD) has been linked to iron‐restricted erythropoiesis imposed by high circulating levels of hepcidin, a 25 amino acid hepatocyte‐derived peptide that controls systemic iron homeostasis. Here, we report the engineering of the human lipocalin‐derived, small protein‐based anticalin PRS‐080 hepcidin antagonist with high affinity and selectivity. Experimental Approach: Anticalin‐ and hepcidin‐specific pharmacokinetic (PK)/pharmacodynamic modelling (PD) was used to design and select the suitable drug candidate based on t1/2 extension and duration of hepcidin suppression. The development of a novel free hepcidin assay enabled accurate analysis of bioactive hepcidin suppression and elucidation of the observed plasma iron levels after PRS‐080‐PEG30 administration in vivo. Key Results: PRS‐080 had a hepcidin‐binding affinity of 0.07 nM and, after coupling to 30 kD PEG (PRS‐080‐PEG30), a t1/2 of 43 h in cynomolgus monkeys. Dose‐dependent iron mobilization and hepcidin suppression were observed after a single i.v. dose of PRS‐080‐PEG30 in cynomolgus monkeys. Importantly, in these animals, suppression of free hepcidin and subsequent plasma iron elevation were sustained during repeated s.c. dosing. After repeated dosing and followed by a treatment‐free interval, all iron parameters returned to pre‐dose values. Conclusions and Implications: In conclusion, we developed a dose‐dependent and safe approach for the direct suppression of hepcidin, resulting in prolonged iron mobilization to alleviate iron‐restricted erythropoiesis that can address the root cause of ACD. PRS‐080‐PEG30 is currently in early clinical development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bph.14143

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Research works printed but not linked: 33

  1. 10.1111/bph.13883 · DOI · Paper page
  2. 10.1093/ndt/gfv302 · DOI · Paper page
  3. 10.2215/CJN.01420406 · DOI · Paper page
  4. 10.1111/bph.13433 · DOI · Paper page
  5. 10.1681/ASN.2014090922 · DOI
  6. 10.1182/blood-2013-06-505792 · DOI · Paper page
  7. 10.1111/bph.12856 · DOI · Paper page
  8. 10.3324/haematol.2012.075515 · DOI · Paper page
  9. 10.1007/s10456-015-9490-5 · DOI
  10. 10.1111/acel.12052 · DOI · Paper page
  11. 10.1093/nar/gkx1121 · DOI · Paper page
  12. HohlbaumAM JensenK AllersdorferA BaehreA Bel AibaRS ChristianJet al. (2011).Exploiting lipocalin biochemistry for the treatment of allergy and asthma: discovery and characterization of an anti‐IL‐4RA therapeutic.C21. NEW TARGETS FOR ASTHMA THERAPY. American Thoracic Society. · doi:10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a4065
  13. Home office, 1989, Animals (Scientific Procedures) act 1986, Code of Practice for the housing and care of animals used in scientific procedures, ISBN 0102107890
  14. 10.1007/s11095-010-0098-6 · DOI · Paper page
  15. 10.1021/ja806857r · DOI
  16. 10.1373/clinchem.2010.149187 · DOI · Paper page
  17. 10.1208/s12248-016-9886-1 · DOI
  18. 10.1371/journal.pone.0075518 · DOI · Paper page
  19. 10.1016/j.kint.2015.10.002 · DOI · Paper page
  20. 10.1371/journal.pone.0083232 · doi:10.1371/journal.pone.0083232
  21. 10.1155/2010/750643 · DOI · Paper page
  22. 10.1126/science.1104742 · DOI · Paper page
  23. 10.1152/ajprenal.2000.279.1.F84 · DOI
  24. 10.1158/1535-7163.MCT-13-0318 · DOI
  25. 10.1016/j.kint.2016.07.019 · DOI · Paper page
  26. 10.1053/j.ajkd.2015.12.020 · DOI · Paper page
  27. Rostoker G, 2012, Hemodialysis‐associated hemosiderosis in the era of erythropoiesis‐stimulating agents: a MRI study, Am J Med, 125, e1
  28. 10.1006/jmbi.2000.3646 · DOI
  29. 10.1073/pnas.0813399106 · DOI
  30. 10.1681/ASN.2015010052 · DOI
  31. 10.1002/ajh.23110 · DOI · Paper page
  32. 10.1182/blood-2007-09-111567 · DOI · Paper page
  33. 10.1208/s12248-010-9222-0 · DOI

Cited by

See all 42

Metadata

Authors
Hohlbaum, A. M., Gille, H., Trentmann, S., Kolodziejczyk, M., Rattenstetter, B., Laarakkers, C. M., Katzmann, G., Christian, H. J., Andersen, N., Allersdorfer, A., Olwill, S. A., Meibohm, B., Audoly, L. P., Swinkels, D. W., & van Swelm, R. P. L.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2018-02-23
Volume
175
Issue
7
Pages
1054-1065
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2782555014
Cited by
42
References
18
FWCI
5.17
Type
journal article
Language
en
Open access
green
Funders
  • European Commission in the context of the FP7 health programme Eurocalin (HEALTH-F4-2011-278408)
  • Pieris Therapeutics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sustained plasma hepcidin suppression and iron elevation by Anticalin‐derived hepcidin antagonist in cynomolgus monkey. https://app.cochat.ai/papers/10.1111/bph.14143
The paper
Hohlbaum, A. M., Gille, H., Trentmann, S., Kolodziejczyk, M., Rattenstetter, B., Laarakkers, C. M., Katzmann, G., Christian, H. J., Andersen, N., Allersdorfer, A., Olwill, S. A., Meibohm, B., Audoly, L. P., Swinkels, D. W., & van Swelm, R. P. L. (2018). Sustained plasma hepcidin suppression and iron elevation by Anticalin‐derived hepcidin antagonist in cynomolgus monkey. British Journal of Pharmacology. https://doi.org/10.1111/bph.14143

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.